Gilead Sciences, Inc. (GILD)

Gilead Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	28,718	28,610	26,934	26,982	27,008	24,355
Revenue Growth (YoY)	3.96%	6.22%	-0.18%	-0.10%	10.89%	10.11%
Cost of Revenue	6,196	6,251	6,498	5,657	6,601	4,572
Gross Profit	22,522	22,359	20,436	21,325	20,407	19,783
Selling, General & Admin	5,963	6,091	6,090	5,673	5,246	5,151
Research & Development	6,714	14,750	6,923	8,621	5,540	10,895
Total Operating Expenses	12,677	20,841	13,013	14,294	10,786	16,046
Operating Income	8,051	1,662	7,605	7,330	9,918	4,071
Interest Expense	1,001	977	944	935	-1,001	-984
Other Non-Operating Income (Expense)	151	6	198	-581	-639	-1,418
Total Non-Operating Income (Expense)	1,152	983	1,142	354	-1,640	-2,402
Pretax Income	7,201	690	6,859	5,814	8,278	1,669
Provision for Income Taxes	890	211	1,247	1,248	-2,077	-1,580
Net Income	6,311	480	5,665	4,592	6,225	123
Minority Interest in Earnings	-	-	-52	-26	24	34
Net Income to Common	6,311	480	5,665	4,592	6,225	123
Net Income Growth	499.34%	-91.53%	23.37%	-26.23%	4960.98%	-97.72%
Shares Outstanding (Basic)	1,246	1,247	1,248	1,255	1,256	1,257
Shares Outstanding (Diluted)	1,262	1,255	1,258	1,262	1,262	1,263
Shares Change (YoY)	0.74%	-0.24%	-0.32%	-	-0.08%	-1.10%
EPS (Basic)	5.05	0.38	4.54	3.66	4.96	0.10
EPS (Diluted)	5.02	0.38	4.50	3.64	4.93	0.10
EPS Growth	519.75%	-91.56%	23.63%	-26.17%	4830.00%	-97.63%
Free Cash Flow	7,431	10,305	7,420	8,344	10,805	7,696
Free Cash Flow Growth	-27.89%	38.88%	-11.07%	-22.78%	40.40%	-7.49%
Free Cash Flow Per Share	5.89	8.21	5.90	6.61	8.56	6.09
Dividends Per Share	3.120	3.080	3.000	2.920	2.840	2.720
Dividend Growth	1.30%	2.67%	2.74%	2.82%	4.41%	7.94%
Gross Margin	78.42%	78.15%	75.87%	79.03%	75.56%	81.23%
Operating Margin	28.03%	5.81%	28.24%	27.17%	36.72%	16.72%
Profit Margin	21.98%	1.68%	20.84%	16.92%	22.96%	0.37%
FCF Margin	25.88%	36.02%	27.55%	30.92%	40.01%	31.60%
EBITDA	10,821	4,429	10,298	9,433	11,968	5,551
EBITDA Margin	37.68%	15.48%	38.23%	34.96%	44.31%	22.79%
EBIT	8,051	1,662	7,605	7,330	9,918	4,071
EBIT Margin	28.03%	5.81%	28.24%	27.17%	36.72%	16.72%
Effective Tax Rate	12.36%	30.58%	18.18%	21.47%	-25.09%	-94.67%

Updated Aug 7, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q